Search Results - J. Lancet

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    P587: COVALENT-101: A PHASE 1 STUDY OF BMF-219, A NOVEL ORAL IRREVERSIBLE MENIN INHIBITOR, IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE LEUKEMIA, DIFFUSE LARGE B-CELL LYMPHOMA, AND M... by F. Ravandi-Kashani, A. Kishtagari, H. Carraway, G. Schiller, E. Curran, B. Yadav, A. Cacovean, S. Morris, T. Butler, J. Lancet

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  2. 2

    P755: HYPERFERRITINEMIA IS A PREDICTIVE BIOMARKER OF POOR CLINICAL OUTCOMES IN CMML by L. E. Aguirre, S. Ball, A. Jain, N. Al Ali, D. Sallman, A. Kuykendall, K. Sweet, J. Lancet, E. Padron, R. Komrokji

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  3. 3

    P1073: MUTATIONAL LANDSCAPE AND CLINICAL OUTCOMES OF PATIENTS WITH MYELOID AND LYMPHOID NEOPLASMS WITH EOSINOPHILIA (MLN-EOS) AND ABNORMALITIES OF PDGFRA, PDGFRB, FGFR1, FLT3 AND J... by Y. Zhang, L. Nguyen, C. Lu, E. Wang, M. Lauw, S. Ball, N. Dong, L. Moscinski, O. Chan, S. Yun, D. Sallman, L. Sokol, B. Shah, J. Lancet, R. Komrokji, A. Kuykendall, E. Padron, L. Zhang

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


Search Tools: